Showing 34,805 results

Harm reduction

Taking Naloxone where it matters

Editor's pick
Addaction / Medium
6 December 2019
Transgender people

The End of NYC’s HIV Epidemic Is In Sight—Except for Trans Women

Editor's pick
Filter
6 December 2019
Combatting stigma

Ending stigma and discrimination is critical to expanding HIV services in Jamaica

Editor's pick
UNAIDS
6 December 2019
Mental & emotional health & wellbeing

Impact of isolation and loneliness on older people living with HIV

Editor's pick
i-Base
6 December 2019
Pharmaceutical industry

Gilead delayed safer HIV drug to extend monopoly profits, advocates allege

Editor's pick
San Francisco Chronicle
6 December 2019
Undetectable viral load & treatment as prevention

Awareness of U=U increasing, but HIV-negative MSM still less likely to believe in its accuracy

News
6 December 2019
The search for an HIV prevention vaccine

Immune system can be coaxed into selecting key antibodies to fight HIV

Editor's pick
EurekAlert
6 December 2019
Finding support

Can Peer Support Programs Help Those Living With HIV?

Editor's pick
Undark
5 December 2019
Health services & systems

Communities together — accelerating uptake of promising new HIV/AIDS medicines

Editor's pick
Devex
5 December 2019
New & experimental HIV treatments

ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available

Editor's pick
5 December 2019
Experiences of stigma

Your own feelings about having HIV

About HIV
December 2019

Annual unaudited trustees' report and financial statements 2019

December 2019
Chemsex & recreational drug use

Chemsex is an emerging issue in the Middle East and eastern Europe

News
5 December 2019
PrEP policies & guidelines

US HHS Hands Out Free HIV Prevention Drugs. Do You Qualify?

Editor's pick
Kaiser Health News
4 December 2019
Bad science & bogus treatments

China’s CRISPR babies: Read exclusive excerpts from the unseen original research

Editor's pick
MIT Technology Review
4 December 2019
PrEP programmes & uptake

Gilead’s converting Truvada PrEP users to Descovy faster than expected: analyst

Editor's pick
FirecePharma
4 December 2019
Weight gain & lipodystrophy

New Formulation of Tesamorelin Available for HIV Patients With Lipodystrophy

Editor's pick
Infectious Disease Advisor
4 December 2019
PrEP policies & guidelines

U.S. to give free HIV-prevention pills to uninsured — with one costly loophole

Editor's pick
NBC News
4 December 2019
The search for an HIV prevention vaccine

The Moon Landing of HIV Vaccine Research: RV144, Ten Years Later

Editor's pick
MedPage Today
4 December 2019
Experiences of stigma

How we internalise stigma and shame

Editor's pick
GroundUp
4 December 2019
Epidemiology & behaviour

Flawed definitions of unsafe sex massively over-estimate how many people are having it

News
4 December 2019

December 2019 (Issue 19)

December 2019
Pharmaceutical industry

HIV Affects Millions of Women. So Why Isn’t a New PrEP Drug Approved for Their Use?

Editor's pick
Rewire News
3 December 2019
People & personal stories

Vuyiseka Dubula-Majola: ‘My anger fed my activist’s soul’

Editor's pick
Daily Maverick
2 December 2019